Administered just twice a year, the drug Lenacapavir offers near-complete protection — more than 99% — against HIV. After years of research and clinical trials, the preventive treatment has been approved and is now set to be rolled out on a large scale. Mass rollout campaigns are planned across Southern Africa — South Africa, Zambia, Eswatini, Zimbabwe, Lesotho and Mozambique — the region hardest hit by HIV/AIDS.
Search
Congressional trades, bills, prediction markets, hearings, and intelligence signals. Signal search supports: AND OR "exact phrase" -exclude
1 signal for Criminal · LS
Page 1 of 1